GORMAN KEVIN CHARLES sold NBIX
February 13, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES sold 2,901 shares of Neurocrine Biosciences, Inc. at $124.12 per share, a transaction worth $360.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,901
Price
$124.12
Total value
$360.1K
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after521,949
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs") or performance restricted stock units ("PRSUs"), as applicable. No shares were sold.